Novartis, bir neçə digər dərman istehsalçısı ilə birlikdə, Lp(a)-nın aşağı salınmasının bəzən ölümcül ürək-damar hadisələrinin riskini azaldacağını düşünür.
Əlaqəli xəbərlər
Deloitte Romania expands management team with three new directors
Oracle’s stock gets a boost as the OpenAI ecosystem comes back into favor
Cathie Wood Just Went Bargain Hunting. Here Are the 3 AI Stocks She Bought.
Prediction: Oracle's $638 Billion Cloud Infrastructure Backlog Could Make It One of the Best-Performing AI Stocks Through 2028
Flipkart begins internal food delivery pilot in Bengaluru, India
Saffery expands client development team with two new appointments